Development of a large animal model of cirrhosis and portal hypertension using hepatic transarterial embolization: A study in swine

Journal of Vascular and Interventional Radiology

Volumn 22, Issue 9, 2011, Pages 1329-1334

  Avritscher, Rony ^a   Wright, Kenneth C ^a   Javadi, Sanaz ^a   Uthamanthil, Rajesh ^b   Gupta, Sanjay ^a   Gagea, Mihai ^b   Bassett, Roland L ^b   Murthy, Ravi ^a   Wallace, Michael J ^a   Madoff, David C ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

hepatic venous pressure gradient; HVPG

Indexed keywords

ALCOHOL; IODINATED POPPYSEED OIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL EMBOLISM; COMPUTER ASSISTED TOMOGRAPHY; HEPATIC ARTERY; LIVER CIRRHOSIS; LIVER FUNCTION TEST; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; SWINE;

ANIMALS; EMBOLIZATION, THERAPEUTIC; ETHANOL; HEPATIC ARTERY; HYPERTENSION, PORTAL; INFUSIONS, INTRA-ARTERIAL; IODIZED OIL; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; LIVER FUNCTION TESTS; ORGAN SIZE; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SUS SCROFA; TIME FACTORS; VENOUS PRESSURE;

EID: 80052034635     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2011.04.016     Document Type: Article

References (22)

1. N.J. Yi, K.S. Suh, and H.W. Lee Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft Liver Transpl 15 2009 496 503
2. National Institute of Diabetes and Digestive and Kidney Diseases Digestive diseases in the United States: epidemiology and impact NIH Publication 941447 1994 US Government Printing Office Washington, DC
3. S.L. Friedman, and M.B. Bansal Reversal of hepatic fibrosisfact or fantasy? Hepatology 43 Suppl 2006 S82 S88
4. D.C. Rockey Antifibrotic therapy in chronic liver disease Clin Gastroenterol Hepatol 3 2005 95 107 (Pubitemid 40220303)
5. D.C. Rockey New therapies in hepatitis C virus and chronic liver disease: antifibrotics Clin Liver Dis 10 2006 881 900 (Pubitemid 44880157)
6. J.G. Abraldes, M. Pasarin, and J.C. Garcia-Pagan Animal models of portal hypertension World J Gastroenterol 12 2006 6577 6584 (Pubitemid 44794932)
7. M.A. Sun, B.E. Wang, and G. Annoni Two rat models of hepatic fibrosis A morphologic and molecular comparison Lab Invest 63 1990 467 475 (Pubitemid 20368726)
8. M.J. Tunon, M. Alvarez, J.M. Culebras, and J. Gonzalez-Gallego An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure World J Gastroenterol 15 2009 3086 3098
9. G. Ugazio, S. Bosia, and E. Cornaglia Experimental model of cirrhosis in rabbits exposed to carbon tetrachloride by inhalation Res Commun Mol Pathol Pharmacol 88 1995 63 77
10. D. Pavcnik, R.R. Saxon, and Y. Kubota Attempted induction of chronic portal venous hypertension with polyvinyl alcohol particles in swine J Vasc Interv Radiol 8 1997 123 128 (Pubitemid 27522861)
11. F.G. Court, S.A. Wemyss-Holden, and C.P. Morrison Segmental nature of the porcine liver and its potential as a model for experimental partial hepatectomy Br J Surg 90 2003 440 444 (Pubitemid 36458106)
12. M. Swindle, and A.C. Smith Comparative anatomy and physiology of the pig Scand J Lab Anim Sci 25 Suppl 1 1998 11 21 (Pubitemid 128549607)
13. D.C. Madoff, S. Gupta, and E.P. Pillsbury Transarterial versus transhepatic portal vein embolization to induce selective hepatic hypertrophy: a comparative study in swine J Vasc Interv Radiol 18 2007 79 93 (Pubitemid 46616672)
14. J. Bosch, J.G. Abraldes, A. Berzigotti, and J.C. Garcia-Pagan The clinical use of HVPG measurements in chronic liver disease Nat Rev 6 2009 573 582
15. P. Bedossa, and T. Poynard An algorithm for the grading of activity in chronic hepatitis C The METAVIR Cooperative Study Group Hepatology 24 1996 289 293 (Pubitemid 26260021)
16. S.L. Friedman, D.C. Rockey, and D.M. Bissell Hepatic fibrosis 2006: report of the Third AASLD Single Topic Conference Hepatology 45 2007 242 249 (Pubitemid 46144384)
17. M. Friedrich-Rust, C. Muller, and A. Winckler Assessment of liver fibrosis and steatosis in PBC with FibroScan, MRI, MR-spectroscopy, and serum markers J Clin Gastroenterol 44 2010 58 65
18. Z. Kan, K. Wright, and S. Wallace Ethiodized oil emulsions in hepatic microcirculation: in vivo microscopy in animal models Acad Radiol 4 1997 275 282 (Pubitemid 127469851)
19. Z. Kan, and S. Wallace Transcatheter liver lobar ablation: an experimental trial in an animal model Eur Radiol 7 1997 1071 1075 (Pubitemid 127537134)
20. R.P. Tamayo Is cirrhosis of the liver experimentally produced by CCl4 an adequate model of human cirrhosis? Hepatology 3 1983 112 120
21. T.F. Slater, K.H. Cheeseman, and K.U. Ingold Carbon tetrachloride toxicity as a model for studying free-radical mediated liver injury Philos Trans R Soc Lond B Biol Sci 311 1985 633 645
22. J.J. Zhang, X.K. Meng, and C. Dong Development of a new animal model of liver cirrhosis in swine Eur Surg Res 42 2009 35 39